Posted:
11/7/2024, 10:16:43 AM
Location(s):
Massachusetts, United States ⋅ Cambridge, Massachusetts, United States
Experience Level(s):
Expert or higher ⋅ Senior
Field(s):
Product
What if you could join a rapidly growing company and play a critical role in bringing new medicines to patients through looking at and treating disease in a revolutionary way?
About Vesalius
Vesalius Therapeutics is pioneering a revolutionary platform to generate breakthrough treatments for common diseases. Vesalius’ platform uses large-scale human genetics, genomics, stem cell studies and artificial intelligence to uncover causal biology and identify optimal intervention points for new therapies. Efficiently identifying these intervention points and the patients most likely to benefit from these novel therapies will enable smaller, shorter clinical trials with a higher probability of success. Vesalius was founded in 2019 by Flagship Pioneering. For more information visit vesaliustx.com, or follow us on X and LinkedIn.
About the Position
Vesalius is seeking an experienced Director, Program and Alliance Management to play a vital role in the company’s efforts to support our external alliances and our internal innovative portfolio of drug discovery programs. The candidate will be responsible for providing strong leadership, organization, risk identification, tracking and mitigation and expertise to support cross-functional teams to execute on program deliverables required to meet the goals of the organization. The successful candidate will work closely with team members across Vesalius and external partners to rapidly advance programs. S/he will be comfortable working in and contributing to a highly dynamic and cross-functional team environment
Responsibilities
Qualifications
Preferred Qualifications
About Flagship
Flagship Pioneering is a bioplatform innovation company that invents and builds platform companies, each with the potential for multiple products that transform human health or sustainability. Since its launch in 2000, Flagship has originated and fostered more than 100 scientific ventures, resulting in more than $90 billion in aggregate value. Many of the companies Flagship has founded have addressed humanity’s most urgent challenges: vaccinating billions of people against COVID-19, curing intractable diseases, improving human health, preempting illness, and feeding the world by improving the resiliency and sustainability of agriculture. Flagship has been recognized twice on FORTUNE’s “Change the World” list, an annual ranking of companies that have made a positive social and environmental impact through activities that are part of their core business strategies, and has been twice named to Fast Company’s annual list of the World’s Most Innovative Companies. Learn more about Flagship at www.flagshippioneering.com
Vesalius is committed to equal employment opportunity regardless of race, color, ancestry, religion, sex, national origin, sexual orientation, age, citizenship, marital status, disability, gender identity or Veteran status.
At Vesalius, we recognize there is no perfect candidate. If you have some of the experience listed above but not all, please apply anyway. Experience comes in many forms, skills are transferable, and passion goes a long way. We are dedicated to building diverse and inclusive teams and look forward to learning more about your unique background.
Recruitment & Staffing Agencies: Vesalius Therapeutics does not accept unsolicited resumes from any source other than candidates. The submission of unsolicited resumes by recruitment or staffing agencies to Vesalius or its employees is strictly prohibited unless contacted directly by the Vesalius internal Talent Acquisition team. Any resume submitted by an agency in the absence of a signed agreement will automatically become the property of Vesalius, and Vesalius will not owe any referral or other fees with respect thereto.
Website: https://vesaliustx.com/
Headquarter Location: Cambridge, Massachusetts, United States
Employee Count: 11-50
Year Founded: 2019
IPO Status: Private
Last Funding Type: Series A
Industries: Health Care ⋅ Medical